YOLFTbeta
30

Sanbo Hospital Management Group Ltd. A

301293 · SHE · Healthcare / Medical Care Facilities

51.62CNY-0.66 (-1.26%)

Price History

Full chart

Market Stats

Previous Close52.28
Open51.50
Day Range51.15 – 53.14
52-Week Range46.83 – 103.00
Volume5.61M
Market Cap10.06B
P/E (TTM)212.39
Forward P/E0.00
EPS0.23
Dividend Yield0.00%
Beta0.85
50-Day Avg52.76
200-Day Avg63.77

About

Sanbo Hospital Management Group Limited, together with its subsidiaries, engages in hospital management in China. The company operates neurology and general hospitals. It is also involved in clinical medical; medical device management; medical investment; and property management services. It also offers neurosurgery services, including brain tumor surgery, cerebral vascular bypass surgery, functional neurosurgery for epilepsy and Parkinson's disease, spinal cord and nerve surgery, and pediatric neurosurgery; neurointervention; neuro-oncology chemotherapy and radiotherapy, including Gamma Knife and linear accelerator treatments; neurocritical care, and perioperative neurological monitoring. Sanbo Hospital Management Group Limited was founded in 2003 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Xiangying Xu
  • Employees2.89K
  • HeadquartersCentury Golden Resources Business Center, Building A, Beijing, China, 10009, China
  • Websitehttps://www.sbnkjt.com

Leadership

  • Mr. Xiangying XuGM & Non-Independent Director · b. 1973
  • Mr. Qiao MinghaoFinance Director · b. 1982
  • Mr. Binbin CaiDeputy GM & Non-Independent Director · b. 1967
  • Mr. Hu WeiweiDeputy GM & Secretary of the Board of Directors · b. 1984
  • Mr. Sun JirangDeputy General Manager · b. 1967
  • Mr. Lin ZhixiongDeputy General Manager · b. 1967
  • Jinling GaoAccounting Supervisor

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.14B1.07B1.31B1.43B1.73B
Growth (%)--5.90%+22.73%+8.84%+20.69%
Cost of Revenue862.66M837.40M1.02B1.09B1.32B
Gross Profit274.56M232.69M294.00M335.75M402.27M
Gross Margin24.14%21.74%22.39%23.49%23.32%
Operating Expense147.91M135.53M160.99M191.68M253.04M
Operating Income126.65M97.16M133.00M144.07M149.24M
Operating Margin11.14%9.08%10.13%10.08%8.65%
EBITDA-192.83M204.96M235.97M242.91M
EBITDA Margin-18.02%15.61%16.51%14.08%
Net Income76.69M63.45M78.24M105.03M84.18M
Net Income Margin6.74%5.93%5.96%7.35%4.88%
Interest Expense11.56M11.59M9.69M7.85M14.05M
Interest Expense % of Total Revenue1.02%1.08%0.74%0.55%0.81%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.79B1.94B3.13B3.53B3.91B
Total Liabilities550.68M558.03M625.95M901.39M1.26B
Total Equity1.13B1.24B2.32B2.30B2.34B
Cash462.33M600.39M822.12M708.35M447.72M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow122.11M152.91M245.54M161.88M188.28M
Capital Expenditure145.18M89.96M169.54M541.76M586.45M
Free Cash Flow-23.07M62.95M76.00M-379.88M-398.17M
Dividends Paid951.87K527.19K554.14K15.05M36.49M
FCF to OCF-18.89%41.17%30.95%-234.67%-211.47%
Dividend Paid to FCF-4.13%0.84%0.73%-3.96%-9.17%

Earnings

Report DateJun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------
EPS Actual0.090.140.030.160.160.190.000.190.150.070.000.070.09
Surprise-------------
Timing-------------

Key Statistics & Ratios

Market Cap10.06B
Enterprise Value10.71B
Trailing P/E212.39
Forward P/E0.00
Price / Sales5.38
Price / Book4.40
EPS0.23
Book Value11.70
Revenue (TTM)1.87B
Gross Profit (TTM)403.04M
EBITDA225.85M
Profit Margin2.53%
Operating Margin9.94%
Return on Equity0.72%
Return on Assets1.89%
Shares Outstanding205.99M
Shares Float157.95M
Beta0.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio64.35%

Dividends

20251×
0.15Jul 9, 2025
20241×
0.10Jun 27, 2024

Stock Splits

  • Jun 27, 20241.3:1